The 23 analysts offering 12-month price forecasts for Sanofi SA have a median target of 61.05, with a high estimate of 70.86 and a low estimate of 45.34. The median estimate represents a +20.20% increase from the last price of 50.79.
The current consensus among 26 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.70
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.